Common Contracts

EX-10.38 3 a2202121zex-10_38.htm EX-10.38 Pursuant to 17 C.F.R §240.24b-2, confidential information (indicated as [***]) has been omitted and has been filed separately with the Securities and Exchange Commission pursuant to a Confidential Treatment...

Distribution Agreement • May 5th, 2020 • New York

• Contract Type
  Distribution Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

THIS AMENDED AND RESTATED DISTRIBUTION AGREEMENT (“Agreement”) is made as of February 21, 2011 (the “Effective Date”), by and between United Therapeutics Corporation (“UT”), a Delaware corporation, with offices at 1040 Spring Street, Silver Spring, Maryland and Accredo Health Group, Inc. (“DISTRIBUTOR”), a Delaware corporation, with offices at 1640 Century Center Parkway, Memphis, Tennessee 38134.

AMENDED AND RESTATED DISTRIBUTION AGREEMENT

Distribution Agreement • February 24th, 2011 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • New York

• Contract Type
  Distribution Agreement
• Filed
  February 24th, 2011
• Company
  UNITED THERAPEUTICS Corp
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS AMENDED AND RESTATED DISTRIBUTION AGREEMENT (“Agreement”) is made as of February 21, 2011 (the “Effective Date”), by and between United Therapeutics Corporation (“UT”), a Delaware corporation, with offices at 1040 Spring Street, Silver Spring, Maryland and Accredo Health Group, Inc. (“DISTRIBUTOR”), a Delaware corporation, with offices at 1640 Century Center Parkway, Memphis, Tennessee 38134.